Head-to-head · Cost-Efficiency Index
G-Plans vs MultiMedRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
G-Plans
Shoppers wanting a nutrition/genotype-assessment angle alongside optional GLP-1 access, willing to complete a quiz to see pricing.
Visit G-PlansMultiMedRx
Patients drawn to the low-friction '$45 to start' entry who are willing to discover full pricing after intake.
Visit MultiMedRxThe verdict
G-Plans and MultiMedRx tie on the Cost-Efficiency Index at 42/100, so neither wins outright on the numbers. For most shoppers we'd start with G-Plans (ranked #512, a hair above #513) — Shoppers wanting a nutrition/genotype-assessment angle alongside optional GLP-1 access, willing to complete a quiz to see pricing. But MultiMedRx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs G-Plans.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | G-Plans | MultiMedRx |
|---|---|---|
| Cost-Efficiency Index | 42/100 | 42/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Yes |
| Rank here | #512 | #513 |
G-Plans
42/100Where the value is
- LegitScript badge displayed
- Confirmed access to both branded (Ozempic) and compounded GLP-1 medications
- Distinctive nutrition-first / metabolic-genotype assessment angle vs. pure drug-dispensing competitors
The tradeoffs
- Zero pricing visible anywhere without completing the full intake quiz
- No named medical director or compounding pharmacy partner
MultiMedRx
42/100Where the value is
- Genuine LegitScript-certified verification badge, confirmed live on the site
- Named, identifiable providers (Adam Mizeracki, MD and Jennifer Faggionato, PA)
- Prescribes real branded GLP-1s (Ozempic, Wegovy, Zepbound), not unregulated compounds
The tradeoffs
- Headline '$45 to start' price is a confirmed promotional entry fee, not the ongoing monthly cost
- Fine print requires 'pre-paid totals' to receive the advertised offer
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.